Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-000069-41Phase 4Active
Phase 4, randomised trial of albumin (human) in Cardiovascular Malformation (CVM) (2 arms), sponsored by Erasmus MC. Primary endpoints: Postoperative hematocrit level and Postoperative platelet count. Started Jan 2008; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-000069-41.